Medical News

RSS
Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

CCBR-SYNARC to expand its Electronic Data Capture capabilities for use in imaging clinical trials

CCBR-SYNARC to expand its Electronic Data Capture capabilities for use in imaging clinical trials

New social networking site for breast cancer survivors

New social networking site for breast cancer survivors

Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards

Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Idenix Pharmaceuticals reports phase I study results of IDX184 for treating HCV

Valeant Pharmaceuticals to acquire prescription and cosmetic products rights from Polish

Valeant Pharmaceuticals to acquire prescription and cosmetic products rights from Polish

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

Walnut Village, a full-service retirement community, officially opens its door to Anaheim residents

Walnut Village, a full-service retirement community, officially opens its door to Anaheim residents

Stockholders of SCM Microsystems approve increase of the amount of common shares

Stockholders of SCM Microsystems approve increase of the amount of common shares

Michigan residents sue State over denied access to dental healthcare

Michigan residents sue State over denied access to dental healthcare

PMSI Holdings to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing

PMSI Holdings to purchase rights under the patent portfolio held by Ronald A. Katz Technology Licensing

Merge Healthcare and MEDRAD announce an expansion of their EU Distribution Agreement for CADstream

Merge Healthcare and MEDRAD announce an expansion of their EU Distribution Agreement for CADstream

Repros Therapeutics signs settlement agreement with major creditors

Repros Therapeutics signs settlement agreement with major creditors

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Eisai reports global Phase III study results of eribulin mesylate

Eisai reports global Phase III study results of eribulin mesylate

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

First Choice Health Services to be included in the top-performing home health agencies in the US

First Choice Health Services to be included in the top-performing home health agencies in the US

Third-quarter fiscal 2009 results announced by HMS Holdings

Third-quarter fiscal 2009 results announced by HMS Holdings

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.